---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-004618"
form_type: "8-K"
ticker: "OBIO"
cik: "0001814114"
company_name: "Orchestra BioMed Holdings, Inc."
filed_at: "2023-01-24T23:59:59+00:00"
generated_at: "2026-06-20T10:57:40.317127+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Health Sciences Acquisitions Corp 2 receives Nasdaq delisting notice for failing to hold annual meeting

## Summary
- Received Nasdaq notice on Jan 19, 2023 for failure to hold annual meeting within 12 months after FY2021 end (Dec 31, 2021).
- Has until March 5, 2023 to submit compliance plan; if accepted, deadline extended to June 29, 2023.
- Company does not intend to submit plan; expects to resolve via business combination with Orchestra BioMed at Jan 24, 2023 meeting.
- If business combination approved, combined company treated as newly listed; annual meeting due by Dec 31, 2024.

## SEC filing metadata
- accession: 0001213900-23-004618
- form_type: 8-K
- ticker: OBIO
- cik: 0001814114
- company_name: Orchestra BioMed Holdings, Inc.
- filed_at: 2023-01-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1814114/000121390023004618/0001213900-23-004618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1814114/000121390023004618/ea172098-8k_healthsci2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-004618
- JSON: https://secwatch.observer/filing/0001213900-23-004618.json
- Plain text: https://secwatch.observer/filing/0001213900-23-004618.txt

## Key facts
- Listing & Compliance Notices
  Orchestra BioMed Holdings, Inc. received a nasdaq deficiency notice notice regarding other (rules 5620(a)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Rules: 5620(a)
  source text: a Cayman Islands exempted company (“ HSAC2 ” or the “ Company ”), received a notice from The Nasdaq Stock Market (“ Nasdaq ”) stating that the Company failed to hold an annual meeting of stockholders within 12 months after its fiscal year ended December 31, 2021, as required by Nasdaq Listing Rule 5620(a). In accordance with Nasdaq Listing Rule 5810(c)(2)(G), the Company has 45 calendar days (or until March 5, 2023) to submit a plan to regain compliance and, if Nasdaq accepts the plan, Nasdaq may grant the Company up to 180 calendar days from its fiscal year end, or until June 29, 2023, to re
  evidence_url: https://www.sec.gov/Archives/edgar/data/1814114/000121390023004618/0001213900-23-004618-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.